FORT WORTH, Texas (October 4, 2019) Galderma, a global leader focused on meeting the world's increasing skin health needs, announced today that the U.S. Food and Drug Administration (FDA) approved Aklief (trifarotene) Cream, 0.005% for the topical…Original Article
FDA Approves Aklief (trifarotene) Cream, a New Topical Retinoid for the Treatment of Acne
